Please Wait.....
Report
Latin America Tumor Ablation Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Latin America Tumor Ablation Market Report and Forecast 2024-2032
Latin America Tumor Ablation Market Outlook
The global tumor ablation market size was valued at USD 1.9 billion in 2023, with Latin America holding a significant market share. The market is driven by the rising introduction of advanced technologies in tumor ablation. It is expected to grow at a CAGR of 12.90% during the forecast period of 2024-2032, with the values likely to attain USD 6.3 billion by 2032.
Key Takeaways
- Recent data reveals that 9 in 10 of the most populous nations in Latin America will observe at least a 64% increase in cancer patients by 2040 . The high cancer incidence is expected to directly impact market demand for this minimally invasive technique.
- One of the major Latin America tumor ablation market trends is the increased initiatives by both public and private organizations to spread awareness about cancer treatment strategies. In October 2023 , the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) announced the first edition of Latin America and the Caribbean Code Against Cancer with the objective of reducing cancer cases in the region.
- The market is also influenced by the minimally invasive nature of tumor ablation therapy which fuels its adoption rate due to shorter recovery times and fewer complications compared to traditional surgeries to treat cancer.
Latin America Tumor Ablation Market Analysis
Tumor ablation is a medical procedure that is utilized to destroy cancer cells in a tumor in various parts of the body, such as the liver, kidney, and bone. Some common tumor ablation approaches include radiofrequency ablation (RFA) and cryoablation. This technique can help in localized destruction of cancerous cells without the need for invasive surgery. Due to its minimally invasive nature, this technique is associated with shorter recovery times and fewer complications than traditional surgeries. Hence, the Latin America tumor ablation market demand is expected to witness a surge in the coming years.
Latin America has a significant burden of cancer which can be attributed to the rising aging populations, lifestyle changes, and genetic factors. Recent data reveals that 9 in 10 of the most populous nations in Latin America will observe at least a 64% increase in cancer patients by 2040. Further, it is estimated that nearly 1 million new cancer cases will occur in Brazil each year, which indicates the urgent need for effective cancer treatment options including tumor ablation techniques for managing different types of cancer. Consequently, the high cancer incidence is expected to drive the Latin America tumor ablation market growth.
The market is also influenced by the increased initiatives by both public and private organizations to tackle the growing cancer burden and spread awareness about its management strategies including advanced procedures like tumor ablation. For instance, in October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) announced the first edition of Latin America and the Caribbean Code Against Cancer with the objective of reducing cancer cases in the region. As a part of the World Code Against Cancer, the new Code will offer latest recommendations based on the most recent scientific evidence, influencing changes in health policies and behaviors to prevent cancer. Such initiatives are likely to heighten public awareness regarding the benefits of tumor ablation therapy and enhance its adoption rate, which is poised to augment the market share.
Latin America Tumor Ablation Market Segmentation??
Market Breakup by Technology
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation Ablation
- Other Ablation Technologies
Market Breakup by Application
- Kidney Cancer
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Bone Cancer
Market Breakup by Mode of Treatment
- Surgical Ablation
- Laparoscopic Ablation
- Percutaneous Ablation
Market Breakup by End User
- Hospitals
- Cancer Specialty Clinics
- Others
Market Breakup by Country
- Brazil
- Argentina
- Mexico
- Others
Latin America Tumor Ablation Market: Competitor Landscape
The key features of the market report include funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Medtronic
- Boston Scientific Corporation
- AngioDynamics
- Mermaid Medical
- HealthTronics
- Galil Medical Inc.
- EDAP TMS S.A.
- Misonix, Inc.
- NeuWave Medical, Inc.
- SonaCare Medical
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Latin America tumor ablation market forecast outlook for 2024-2032?
The Latin America tumor ablation market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 14.2% during the forecast period of 2024-2032 and is likely to reach a market value of USD 6.3 billion by 2032.
- What are the major factors aiding the Latin America tumor ablation market demand?
The rising demand for minimally invasive techniques to treat cancer is fuelling the demand for the market.
- What are the major Latin America tumor ablation market trends?
One of the significant trends in the market is the increased initiatives by both public and private organizations to spread awareness about cancer treatment strategies. In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) announced the first edition of Latin America and the Caribbean Code Against Cancer with the objective of reducing cancer cases in the region.
- What is the market segmentation based on the type?
Based on the type, the market is segmented into adenoviral vectors, adeno-associated viral (AAV) vectors, lentiviral vectors, and retroviral vectors, among others.
- What is the market breakup by therapeutic area?
By therapeutic area, the market is divided into oncological disorders, neurological disorders, metabolic disorders, and immunological disorders, among others.
- What are the major end users of the market?
End users of the market are research organizations, biotech, and pharmaceutical companies, among others.
- What are the applications of the market?
Major applications of tumor ablation include gene therapy, cell therapy, and vaccines.
- What is the market segmentation by countries?
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
- Who are the key players involved in the Latin America tumor ablation market?
The key players in the market are Medtronic, Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., Misonix, Inc., NeuWave Medical, Inc., and SonaCare Medical.
Meta description
The Latin America tumor ablation market is poised for growth, driven by the expansion of the global market, which was valued at USD 1.9 billion in 2023 and is projected to grow at a CAGR of 14.2% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Tumor Ablation Market Overview
3.1 Latin America Tumor Ablation Market Historical Value (2017-2023)
3.2 Latin America Tumor Ablation Market Forecast Value (2024-2032)
4 Latin America Tumor Ablation Market Landscape*
4.1 Latin America Tumor Ablation: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Tumor Ablation: Product Landscape
4.2.1 Analysis by Technology
4.2.2 Analysis by Application
5 Latin America Tumor Ablation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Tumor Ablation Market Segmentation (2017-2032)
6.1 Latin America Tumor Ablation Market (2017-2032) by Technology
6.1.1 Market Overview
6.1.2 Radiofrequency Ablation
6.1.3 Microwave Ablation
6.1.4 Cryoablation
6.1.5 Irreversible Electroporation Ablation
6.1.6 Other Ablation Technologies
6.2 Latin America Tumor Ablation Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Kidney Cancer
6.2.3 Liver Cancer
6.2.4 Breast Cancer
6.2.5 Lung Cancer
6.2.6 Prostate Cancer
6.2.7 Bone Cancer
6.3 Latin America Tumor Ablation Market (2017-2032) by Mode of Treatment
6.3.1 Market Overview
6.3.2 Surgical Ablation
6.3.3 Laparoscopic Ablation
6.3.4 Percutaneous Ablation
6.4 Latin America Tumor Ablation Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Cancer Specialty Clinics
6.4.4 Others
6.5 Latin America Tumor Ablation Market (2017-2032) by Country
6.5.1 Market Overview
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Others
7 Brazil Tumor Ablation Market (2017-2032)
7.1 Brazil Tumor Ablation Market (2017-2032) by Technology
7.1.1 Market Overview
7.1.2 Radiofrequency Ablation
7.1.3 Microwave Ablation
7.1.4 Cryoablation
7.1.5 Irreversible Electroporation Ablation
7.1.6 Other Ablation Technologies
7.2 Brazil Tumor Ablation Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Kidney Cancer
7.2.3 Liver Cancer
7.2.4 Breast Cancer
7.2.5 Lung Cancer
7.2.6 Prostate Cancer
7.2.7 Bone Cancer
7.3 Brazil Tumor Ablation Market (2017-2032) by Mode of Treatment
7.3.1 Market Overview
7.3.2 Surgical Ablation
7.3.3 Laparoscopic Ablation
7.3.4 Percutaneous Ablation
7.4 Brazil Tumor Ablation Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Cancer Specialty Clinics
7.4.4 Others
8 Argentina Tumor Ablation Market (2017-2032)
8.1 Argentina Tumor Ablation Market (2017-2032) by Technology
8.1.1 Market Overview
8.1.2 Radiofrequency Ablation
8.1.3 Microwave Ablation
8.1.4 Cryoablation
8.1.5 Irreversible Electroporation Ablation
8.1.6 Other Ablation Technologies
8.2 Argentina Tumor Ablation Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Kidney Cancer
8.2.3 Liver Cancer
8.2.4 Breast Cancer
8.2.5 Lung Cancer
8.2.6 Prostate Cancer
8.2.7 Bone Cancer
8.3 Argentina Tumor Ablation Market (2017-2032) by Mode of Treatment
8.3.1 Market Overview
8.3.2 Surgical Ablation
8.3.3 Laparoscopic Ablation
8.3.4 Percutaneous Ablation
8.4 Argentina Tumor Ablation Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Cancer Specialty Clinics
8.4.4 Others
9 Mexico Tumor Ablation Market (2017-2032)
9.1 Mexico Tumor Ablation Market (2017-2032) by Technology
9.1.1 Market Overview
9.1.2 Radiofrequency Ablation
9.1.3 Microwave Ablation
9.1.4 Cryoablation
9.1.5 Irreversible Electroporation Ablation
9.1.6 Other Ablation Technologies
9.2 Mexico Tumor Ablation Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Kidney Cancer
9.2.3 Liver Cancer
9.2.4 Breast Cancer
9.2.5 Lung Cancer
9.2.6 Prostate Cancer
9.2.7 Bone Cancer
9.3 Mexico Tumor Ablation Market (2017-2032) by Mode of Treatment
9.3.1 Market Overview
9.3.2 Surgical Ablation
9.3.3 Laparoscopic Ablation
9.3.4 Percutaneous Ablation
9.4 Mexico Tumor Ablation Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Hospitals
9.4.3 Cancer Specialty Clinics
9.4.4 Others
10 Regulatory Framework
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Medtronic
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Boston Scientific Corporation
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Angiodynamics
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Mermaid Medical
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 HealthTronics
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Galil Medical Inc.
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 EDAP TMS S.A.
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Misonix, Inc.
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Neuwave Medical, Inc.
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 SonaCare Medical
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 Latin America Tumor Ablation Market - Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security